Cargando…
MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
MYC is a notorious oncogene in a vast network of malignancies, whereas liver-specific microRNA- (miR-) 122-5p is downregulated in hepatocellular cancer (HCC). Here, we studied the possible correlation between these two and their involvement in glycolysis in HCC. MYC was overexpressed in HCC tissues...
Autores principales: | Wang, Xiaofei, Zhang, Penghua, Deng, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410951/ https://www.ncbi.nlm.nih.gov/pubmed/36033372 http://dx.doi.org/10.1155/2022/1435173 |
Ejemplares similares
-
FAM46B Promotes Apoptosis and Inhibits Glycolysis of Prostate Cancer Through Inhibition of the MYC-LDHA Axis
por: Liang, Tao, et al.
Publicado: (2020) -
The c-Myc–LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer
por: He, Tian-Lin, et al.
Publicado: (2015) -
LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial–Mesenchymal Transition
por: Cai, Hongshi, et al.
Publicado: (2019) -
Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma
por: Luo, Jie, et al.
Publicado: (2013) -
Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
por: Chun, Kwang-Hoon
Publicado: (2022)